Gregory Lip - Articles and news items

Boehringer Ingelheim logo

Asian populations with atrial fibrillation benefit from better stroke prevention with Pradaxa® compared to warfarin

Industry news, News / 12 September 2012 / Boehringer Ingelheim

New findings presented at the 2nd Asia Pacific Stroke Conference…

Boehringer Ingelheim logo

PRADAXA® (dabigatran etexilate) first drug in 50 years to gain approval for stroke prevention in atrial fibrillation in Europe

Industry news, News / 4 August 2011 / Ogilvy Healthworld UK Limited

Pradaxa®1 (dabigatran etexilate) approved…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+